The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms.

The DARWIN EU links national databases to deliver real-world evidence that supports safer and faster regulatory decisions.

Disc Medicine, Inc. (NASDAQ:IRON), a $2.07 billion market cap biopharmaceutical company focused on developing treatments for serious hematologic diseases, has been garnering attention from investors ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

(The Conversation is an independent and nonprofit source of news, analysis and commentary ... s classroom file with their medication. At school, ensure your child’s inhaler is clearly labeled. Put a ...

President Donald Trump announced Monday that the US Food and Drug Administration will be notifying physicians that the use of ...

A drug usually prescribed for diabetes has been hailed as something akin to a miracle drug, but until now, scientists haven't ...

Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...

President Trump said pregnant women should "fight like hell" to avoid taking the drug, contrary to medical advice.

After President Trump’s Monday announcement, pregnant women were left wondering what they should take if they feel ill.